pretty much an endless stream of rehashed pumps, and of course, these are unbiased heartfelt benevolent selfless gifts to us:
This Latest Study Adds 1 More Piece to the Alzheimer's Puzzle at Motley Fool (Sun, Aug 2)
The Blockbuster Potential of Biogen Inc's Pipelineat Motley Fool(Sat, Aug 1)
Attention New Biotech Investors: Biogen Inc's Recent Weakness Is Your Opportunity at Motley Fool(Thu, Jul
Pretty interesting how hard the pumping continues. And its pretty much a joke too with "news" reports consisting entirely of old news. It's either a desperation move, or more sinisterly, Cramer & collaborators drove it done so they can drive it back up. Either way, not necessarily a bad thing if you are long and didn't get shaken out.
With orphan drug status was certainly quickest path to income to fund all the other clinical trials they would like to do. Rate of cash burn is already higher than I'd like to see.
Sentiment: Strong Buy
oooh very scary. I'm going to exit this ohterwise exciting prospect exactly for the reasons you exceedingly cite.
How could the future possibly have looked more bleak then, compared to now?
a good scam like this never grows old. great work if you can pull it off. but this one, its the best. how many years and how many dollars? CTIC is the master scam of all scams
hey today is a good day in the life of CTIC relative to most. stock price hardly down, no reverse split, no dilution, no lies spewing from the ceo, no comments of frustration from fda
In october 2000, one share of CTIC was $97000. That must be a mistake right? I guess that's why they invented log scales.
not siginficantly so - but if I was a patient I'd chose the one that gave the extra 2 months - and, more importantly, side effects are less than standard of care. Which one would you chose for yourself? Always need to think about clinical signicance versus statistical significance. hey but I'm only a arthritis doc.